ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07655
0,07%
Bitcoin
63.895,09
-0,16%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LAB
DatumZeitQuelleÜberschriftSymbolFirma
25/04/202414h01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
25/04/202414h00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
08/04/202414h00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
03/04/202422h01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
18/03/202413h12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
07/03/202401h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
28/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
28/02/202422h01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
26/02/202422h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
26/02/202414h00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
22/02/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
22/02/202422h05GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
14/02/202421h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
14/02/202414h30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
08/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
08/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
07/02/202414h30GlobeNewswire Inc.Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineNASDAQ:LABStandard BioTools Inc
02/02/202422h49Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LABStandard BioTools Inc
19/01/202423h07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
19/01/202423h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
19/01/202423h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
19/01/202422h48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
19/01/202422h33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LABStandard BioTools Inc
12/01/202420h04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
10/01/202402h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202400h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202400h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
DBI
TDXP
Tec DAX
AMEX
XLV
Health Care Select Sector
TG
D7G
Nel ASA
USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
FX
EURGBP
Euro vs Sterling
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
DBI
SDXP
SDAX
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten